Katja Zimmermann

7.9k total citations · 2 hit papers
27 papers, 2.3k citations indexed

About

Katja Zimmermann is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Katja Zimmermann has authored 27 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Immunology. Recurrent topics in Katja Zimmermann's work include Cell death mechanisms and regulation (4 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Biochemical and Molecular Research (3 papers). Katja Zimmermann is often cited by papers focused on Cell death mechanisms and regulation (4 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Biochemical and Molecular Research (3 papers). Katja Zimmermann collaborates with scholars based in Germany, United States and United Kingdom. Katja Zimmermann's co-authors include Douglas R. Green, Christine Bonzon, Mario Sarbia, Karsten Schrör, Artur‐Aron Weber, F Borchard, Helmut E. Gabbert, Jean‐Ehrland Ricci, Nathalie Droin and Artur-Aron Weber and has published in prestigious journals such as Circulation, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Katja Zimmermann

27 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The machinery of programmed cell death

2001 668 citations Katja Zimmermann, Christine Bonzon et al. Pharmacology & Therapeutics profile →
Cyclooxygenase-2 expression in human esophageal carcinoma.

1999 585 citations Katja Zimmermann, Mario Sarbia et al. profile →

Peers

Countries citing papers authored by Katja Zimmermann

Since Specialization

Citations

This map shows the geographic impact of Katja Zimmermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Zimmermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Zimmermann more than expected).

Fields of papers citing papers by Katja Zimmermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja Zimmermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Zimmermann. The network helps show where Katja Zimmermann may publish in the future.

Co-authorship network of co-authors of Katja Zimmermann

This figure shows the co-authorship network connecting the top 25 collaborators of Katja Zimmermann. A scholar is included among the top collaborators of Katja Zimmermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katja Zimmermann. Katja Zimmermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery and Preclinical Characterization of Fulacimstat (BAY 1142524), a Potent and Selective Chymase Inhibitor As a New Profibrinolytic Approach for Safe Thrombus Resolution 2024 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Heinrich Meier, Alexander Straub, Joachim Mittendorf, Jens Schamberger, Martina Schäfer, (unknown), (unknown), (unknown), Katja Zimmermann, Adrian Tersteegen, (unknown), Elke Hartmann, Barbara Albrecht‐Küpper, Pedro D’Orléans-Juste, (unknown), (unknown), Stefan Heitmeier, Hanna Tinel	1
2	BAY-069, a Novel (Trifluoromethyl)pyrimidinedione-Based BCAT1/2 Inhibitor and Chemical Probe 2022 ·Journal of Medicinal Chemistry ·(unknown), R.C. Hillig, Katja Zimmermann, Stefan Kaulfuß, Clara Lemos, Duy Nguyen, Hartmut Rehwinkel, Matthew Habgood, Christian Lechner, Roland Neuhaus, (unknown), M. W. Drewes, Jijie Chai, (unknown)	14
3	Crystal structures of the selenoprotein glutathione peroxidase 4 in its apo form and in complex with the covalently bound inhibitor ML162 2021 ·Acta Crystallographica Section D Structural Biology ·Dieter Moosmayer, A. Hilpmann, (unknown), (unknown), Katja Zimmermann, Volker Badock, Laura Furst, John K. Eaton, Vasanthi S. Viswanathan, Stuart L. Schreiber, Stefan Gradl, R.C. Hillig	89
4	The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies 2019 ·Leukemia ·Sven Christian, Claudia Merz, Laura Evans, Stefan Gradl, Henrik Seidel, Anders Friberg, Ashley Eheim, Pascale Lejeune, Krzysztof Brzezinka, Katja Zimmermann, Steven Ferrara, Hanna Meyer, Ralf Lesche, Detlef Stoeckigt, Marcus Bauser, Andrea Haegebarth, David B. Sykes, David T. Scadden, Julie-Aurore Losman, Andreas Janzer	146
5	Abstract 13624: A Novel Chymase Inhibitor BAY 1142524 Reduces Fibrosis and Improves Cardiac Function After Myocardial Infarction in Hamster 2017 ·Circulation ·Hanna Tinel, (unknown), Katja Zimmermann, Adrian Tersteegen, (unknown), (unknown), (unknown), (unknown)	4
6	A pilot trial of doxorubicin containing phosphatidyldiglycerol based thermosensitive liposomes in spontaneous feline soft tissue sarcoma 2016 ·International Journal of Hyperthermia ·Katja Zimmermann, Martin Hossann, Johannes Hirschberger, (unknown), Michael Peller, Moritz Schneider, Andreas Brühschwein, Andrea Meyer‐Lindenberg, Gerhard Wess, Melanie Wergin, (unknown), Thomas Knösel, Markus Schwaiger, Christine Baumgartner, (unknown), (unknown), Lars H. Lindner	33
7	Abstract 2645: BAY 1436032: A highly selective, potent and orally available inhibitor of mutant forms of IDH1 2016 ·Cancer Research ·Olaf Panknin, Stefan Pusch, (unknown), Stefan Kaulfuß, Katja Zimmermann, Hartmut Rehwinkel, Roland Neuhaus, (unknown), (unknown), (unknown), Katja Prelle, Martin Michels, Michael Jeffers, Holger Hess‐Stumpp, Karl Ziegelbauer, Michael Brands, Alwin Krämer, Andreas von Deimling	1
8	Inter-professional in-situ simulated team and resuscitation training for patient safety: Description and impact of a programmatic approach 2015 ·BMC Medical Education ·Katja Zimmermann, (unknown), (unknown), (unknown), (unknown), Meredith Allen, Margarita Burmester, Martin Stocker	33
9	Chronic Therapy With a Partial Adenosine A1-Receptor Agonist Improves Left Ventricular Function and Remodeling in Dogs With Advanced Heart Failure 2013 ·Circulation Heart Failure ·Hani N. Sabbah, Ramesh C. Gupta, Smita Kohli, Mengjun Wang, Sharad Rastogi, Kefei Zhang, Katja Zimmermann, Nicole Diedrichs, Barbara Albrecht‐Küpper	56
10	Selective Attenuation of Norepinephrine Release and Stress-Induced Heart Rate Increase by Partial Adenosine A1 Agonism 2011 ·PLoS ONE ·Lorenz Bott‐Flügel, Alexandra Bernshausen, Heike Schneider, Peter B. Luppa, Katja Zimmermann, Barbara Albrecht‐Küpper, Raimund Kast, Karl‐Ludwig Laugwitz, Heimo Ehmke, (unknown), Melchior Seyfarth	25
11	Löslichkeit von Schwefeldioxid in wässrigen Systemen bei höheren Elektrolytkonzentrationen II. Bromidhaltige Systeme 2009 ·Chemie Ingenieur Technik ·Katja Zimmermann, Christoph Pasel, M. Luckas, Jan-Dirk Herbell	1
12	Solubility of sulphur dioxide in aqueous electrolyte solutions at higher ionic strengths—Chloride and bromide containing systems 2009 ·Fluid Phase Equilibria ·Katja Zimmermann, Christoph Pasel, M. Luckas, Jan-Dirk Herbell	12
13	Löslichkeit von Schwefeldioxid in wässrigen Systemen bei höheren Elektrolytkonzentrationen – I. Chloridhaltige Systeme 2008 ·Chemie Ingenieur Technik ·Katja Zimmermann, Christoph Pasel, M. Luckas, Jan-Dirk Herbell	4
14	The role of ARK in stress-induced apoptosis in Drosophila cells 2002 ·The Journal of Cell Biology ·Katja Zimmermann, Jean‐Ehrland Ricci, Nathalie Droin, Douglas R. Green	140
15	The machinery of programmed cell death breakdown → 2001 ·Pharmacology & Therapeutics ·Katja Zimmermann, Christine Bonzon, Douglas R. Green	668
16	How cells die: Apoptosis pathways☆☆☆ 2001 ·Journal of Allergy and Clinical Immunology ·Katja Zimmermann, Douglas R. Green	248
17	In the company of killers 2001 ·Trends in Molecular Medicine ·Katja Zimmermann, Michael J. Pinkoski	3
18	Aspirin Induces Apoptosis through Release of Cytochrome c from Mitochondria 2000 ·Neoplasia ·Katja Zimmermann, Nigel J. Waterhouse, Joshua C. Goldstein, Martin Schüler, Douglas R. Green	87
19	Constitutive Cyclooxygenase-2 Expression in Healthy Human and Rabbit Gastric Mucosa 1998 ·Molecular Pharmacology ·Katja Zimmermann, Mario Sarbia, (unknown), Artur-Aron Weber	87
20	Augmented myocardial ischaemia by nicotine – Mechanisms and their possible significance 1998 ·British Journal of Pharmacology ·Karsten Schrör, Katja Zimmermann, (unknown)	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact